The National Association of Chain Drug Stores (NACDS) announced this week a request for proposals (RFP) that it will use to create two awards of $300,000 each for demonstration projects that will cultivate alliances across the health care platform to increase immunizations based in pharmacies. Read More »

The U.S. Food and Drug Administration (FDA) announced this week that Briviact (brivaracetam) has been approved as a treatment of epileptic seizures by being added on to other medications. Read More »

McKesson Specialty Health announced this week that the Scottsdale Area Chamber of Commerce has awarded its Reimbursement, Access & Services Solution Center the Sterling Award. Read More »

AstraZeneca and its research and development subsidiary, MedImmune, announced this week that the United States Food and Drug Administration (FDA) has granted durvalumab (MEDI4736) Breakthrough Therapy designation (BTD). Read More »

BioPlus Specialty Pharmacy has announced that its Pay it Forward program will be extended into 2016. Read More »

Amgen announced this week that the Phase 3 Aranesp (darbepoetin alfa) ARCADE trial succeeded in reducing the occurrence of red blood cell transfusions for patients with low and intermediate-1 risk Myelodysplastic Syndrome (MDS) who are also anemic. Read More »

BodyMcKesson announced this week that KLAS, an independent health research firm, has named McKesson Labs 2015/2016 Best in KLAS for Laboratory. Read More »

Daiichi Sankyo Co. announced last week that its oncolytic virus (G47) has received designation under the SAKIGATE Designation System for medical equipment, in vitro diagnostic pharmaceuticals and regenerative medicinal products. Read More »

Aetna and Mount Sinai Health Partners, a group that consists of Mount Sinai Health Systems and volunteers, have announced that the two organizations have come together to form a partnership with the goal of improving coordinated care for patients and decreasing health care costs. Read More »

Actinium Pharmaceuticals announced this week that it will be sending personnel from clinical and business development to the annual BMT Tandem Meetings held by the Center for International Blood & Marrow Transplant Research (CIBMTR) and the American Society of Blood and Marrow Transplantation (ASBMT). Read More »

Pfizer has announced that an agreement has been reached by its subsidiary, Wyeth, to resolve claims that its practice in calculating Medicaid rebates violated the Federal Civil False Claims Act and other laws. Read More »

The Cigna Foundation announced last week that it plans to make Community Health Navigation a priority moving forward with its World of Difference grants in the United States. Read More »

Florida Accountable Care Services (FACS) and UnitedHealthcare announced this week a joint-collaboration to introduce an accountable care program to help the enhancement of patients’ health and overall health care satisfaction. Read More »

Aetna, a nationwide leader in diversified health care benefits, has announced this week that it has purchased Humana’s affiliates located in Florida. Read More »

Renewed calls for a federal ban on prescription drug advertising to consumers needs to be squashed immediately, the Association of National Advertisers (ANA) says. Read More »

US Oncology Research announced recently that it has found and recruited its 2,000th patient to take part in a Phase I clinical trial through its Translational Oncology Program (TOP). Read More »

Upsher-Smith Laboratories Inc. and the National Alliance of State Pharmacy Associations (NASPA) have partnered to honor 43 pharmacists from across the United States with the 2015 NASPA Excellence in Innovation Award. Read More »

Eisai Co. and Sysmex Corp. made a joint announcement this week declaring that the two companies have agreed on a non-exclusive partnership to develop new diagnostics for the field of dementia. Read More »

Sandoz, a company owned by Novartis, announced last week that it has procured the rights to develop and commercialize PF_06438179 (infliximab) from Pfizer. Read More »

Chattem Inc., a subsidiary of Sanofi, announced last week that its product, ACT Advanced Care Mouthwash, has been named the recipient of the 2016 Product of the Year award. Read More »